BioSante Pharmaceuticals, Inc. (BPAX)

[Just the facts maam]

Little known fact Cell Genesys which was bought out by Biosante was formed in 1988. In 1996 Cell Genesys Launches Abgenix Cell Genesys spun out its antibody therapy business into a wholly-owned subsidiary, Abgenix, Inc. Abgenix went public in 1998 and became a Nasdaq-100® company in 2000. In 2006 Abgenix was purchased by Amgen for $2.2.billion the prize product brought from Abgenix was Vectibix® (panitumumab) The only FDA-approved anti-EGFR monoclonal antibody with every-other-week dosing.

Technically Elestrin is not the only product developed by Biosante (Cell Genesis) to get FDA approval.

Cell Genesys History

Sale of Abgenix

Vectibix® (panitumumab)